Utilizing the Skin Transcriptome as a Tool for Biomarker Profiling and Measurements of Efficacy

Time: 11:45 am
day: Day One Clinical Track AM


  • Exploring MADAD transcriptome, a gene signature for key pathways of AD to evaluate therapeutic responses
  • Showing the clinical efficacy of RAPT193 with improved MADAD transcriptome
  • Utilizing the skin transcriptome beyond CCR4 antagonism